Opportunity Information: Apply for 72061219RFA00005
Expanding Malawi HIV/AIDS Prevention with Local Organizations Working for an Effective Epidemic Response (EMPOWER) is a USAID Malawi grant opportunity designed as a five-year program to reduce new HIV infections in Malawi, focusing specifically on PEPFAR priority districts and on populations at higher risk or historically underserved by prevention services. The central idea is to expand the reach and consistent use of proven, high-impact HIV prevention interventions, while also strengthening HIV case-finding so that people living with HIV who have not yet been diagnosed can be identified and connected quickly to antiretroviral treatment (ART). In practice, this means the program is not only about preventing transmission, but also about closing diagnosis gaps and accelerating linkage to care as a core part of epidemic control.
The opportunity is structured as a set of cooperative agreements, which typically indicates a more hands-on partnership between the funder and the recipient compared to a standard grant. USAID plans to make up to five awards, with the expectation that local or non-governmental organizations will implement one or more integrated prevention components. The program allows for flexible packaging: an applicant might compete to implement a single component, or propose a larger, combined approach that covers multiple components under one award, depending on capacity, geographic coverage, and technical strategy.
EMPOWER is organized around three main HIV prevention service areas described in the notice. The first is Voluntary Medical Male Circumcision (VMMC), a well-established biomedical prevention intervention that reduces the risk of female-to-male HIV transmission. USAID anticipates up to two awards for this component, suggesting an intention to support more than one implementing partner to expand service delivery, maintain quality, and meet ambitious coverage targets in priority districts. The second area is DREAMS services for adolescent girls and young women (AGYW) paired with HIV case-finding. DREAMS typically refers to a layered package of interventions intended to reduce HIV vulnerability among AGYW by addressing both direct risk and underlying drivers such as gender-based violence, economic insecurity, and barriers to education and health services; the inclusion of case-finding signals an emphasis on identifying undiagnosed infections within these networks and ensuring linkage to treatment. The third area is Comprehensive Condom Programming (CCP), which generally emphasizes not only condom distribution but also demand creation, correct and consistent use messaging, supply chain reliability, and targeted outreach to populations and settings where condoms have the highest preventive impact.
From an administrative standpoint, the funding opportunity is issued by USAID in Lilongwe, Malawi, under the funding opportunity number 72061219RFA00005, and it uses the cooperative agreement instrument. It is categorized under the health funding activity area (CFDA 98.001) and listed as an earmark opportunity. The stated award ceiling is USD 33,000,000, indicating the maximum amount available per award or across the opportunity as specified in the notice, and awards were expected to be made within the overall plan to fund up to five agreements. The original closing date for submissions was October 16, 2019, and the opportunity record was created on August 26, 2019.
Overall, EMPOWER is positioned as a targeted prevention and case-finding initiative meant to help accelerate epidemic control in Malawi by scaling interventions with strong evidence behind them, prioritizing districts and communities most affected, and pairing prevention scale-up with a deliberate push to find undiagnosed HIV cases and link people to ART. The design also reflects a strong role for non-governmental and local organizations as implementing partners, with the ability to coordinate multiple prevention strategies in a single, coherent district-level response when appropriate.Apply for 72061219RFA00005
- The Malawi USAID-Lilongwe in the health sector is offering a public funding opportunity titled "Expanding Malawi HIV/AIDS Prevention with Local Organizations Working for an Effective Epidemic Response (EMPOWER)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
- This funding opportunity was created on 2019-08-26.
- Applicants must submit their applications by 2019-10-16. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $33,000,000.00 in funding.
- Eligible applicants include: Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: Malawi USAID-Lilongwe
Browse more opportunities from the same category: Health
Next opportunity: International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)
Previous opportunity: Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for 72061219RFA00005
Applicants also applied for:
Applicants who have applied for this opportunity (72061219RFA00005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Health Workforce Improvement Program (HWIP) Apply for 72066319RFA00005 Funding Number: 72066319RFA00005 Agency: Ethiopia USAID-Addis Ababa Category: Health Funding Amount: $39,500,000 |
| Multisite Clinical Center Common Fund Acute to Chronic Pain Signatures Program: Acute Peri-operative Pain or Musculoskeletal Trauma (UM1 Clinical Trial Optional) Apply for RFA RM 19 013 Funding Number: RFA RM 19 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed) Apply for PAR 19 364 Funding Number: PAR 19 364 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Planning Grant for Global Infectious Disease Research Training Program (D71 No Clinical Trials Allowed) Apply for PAR 19 362 Funding Number: PAR 19 362 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed) Apply for PAR 19 357 Funding Number: PAR 19 357 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Trans-Agency Blood-Brain Interface Program (R61/R33 - Clinical Trials Not Allowed) Apply for RFA HL 20 021 Funding Number: RFA HL 20 021 Agency: National Institutes of Health Category: Health Funding Amount: $425,000 |
| Mechanistic Basis of TDP-43-dependent Pathobiology in Common Dementias (R01 Clinical Trial not Allowed) Apply for RFA NS 20 005 Funding Number: RFA NS 20 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Peripheral Pathology in the Lewy Body Dementias (R01 Clinical Trial Not Allowed) Apply for RFA NS 20 014 Funding Number: RFA NS 20 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed) Apply for PAR 19 370 Funding Number: PAR 19 370 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed) Apply for PAR 19 366 Funding Number: PAR 19 366 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing Investigators' Research Award (R35 - Clinical Trial Optional) Apply for PAR 19 367 Funding Number: PAR 19 367 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) Apply for RFA HL 20 022 Funding Number: RFA HL 20 022 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed) Apply for PAR 19 369 Funding Number: PAR 19 369 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed) Apply for PAR 19 371 Funding Number: PAR 19 371 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) Apply for PAR 19 372 Funding Number: PAR 19 372 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial Required) Apply for RFA AG 20 045 Funding Number: RFA AG 20 045 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed) Apply for RFA OD 19 027 Funding Number: RFA OD 19 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Allowed) Apply for RFA AI 19 063 Funding Number: RFA AI 19 063 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) Apply for PAR 19 374 Funding Number: PAR 19 374 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Innovative Programs to Enhance Research Training (IPERT) (R25 - Independent Clinical Trial Not Allowed) Apply for PAR 19 383 Funding Number: PAR 19 383 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "72061219RFA00005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
